Kavitha Ranganathan, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Ossification, Heterotopic | 12 | 2018 | 239 | 2.760 |
Why?
|
Cleft Lip | 10 | 2020 | 478 | 2.290 |
Why?
|
Cleft Palate | 10 | 2020 | 560 | 2.230 |
Why?
|
Surgery, Plastic | 6 | 2023 | 624 | 2.040 |
Why?
|
Burns | 9 | 2024 | 1815 | 1.400 |
Why?
|
Breast Implantation | 3 | 2018 | 218 | 1.060 |
Why?
|
Osteogenesis | 7 | 2018 | 1299 | 1.010 |
Why?
|
Mesenchymal Stem Cells | 10 | 2022 | 1632 | 0.960 |
Why?
|
Feminization | 1 | 2024 | 23 | 0.960 |
Why?
|
Craniosynostoses | 4 | 2021 | 401 | 0.800 |
Why?
|
Sex Reassignment Surgery | 1 | 2023 | 130 | 0.750 |
Why?
|
Income | 4 | 2023 | 1913 | 0.730 |
Why?
|
Mass Casualty Incidents | 1 | 2023 | 183 | 0.730 |
Why?
|
Skull | 5 | 2019 | 814 | 0.730 |
Why?
|
Developing Countries | 3 | 2023 | 2815 | 0.710 |
Why?
|
Burn Units | 1 | 2020 | 136 | 0.710 |
Why?
|
Mercaptoethylamines | 1 | 2018 | 4 | 0.650 |
Why?
|
Amifostine | 1 | 2018 | 41 | 0.640 |
Why?
|
Research Personnel | 1 | 2023 | 573 | 0.630 |
Why?
|
Resource Allocation | 1 | 2020 | 341 | 0.620 |
Why?
|
Radiation-Protective Agents | 1 | 2018 | 90 | 0.620 |
Why?
|
Radiation Injuries, Experimental | 1 | 2018 | 91 | 0.620 |
Why?
|
Psoas Muscles | 2 | 2018 | 71 | 0.600 |
Why?
|
Surgical Procedures, Operative | 2 | 2019 | 1877 | 0.580 |
Why?
|
Disaster Planning | 1 | 2023 | 549 | 0.570 |
Why?
|
Quality of Life | 6 | 2024 | 12802 | 0.540 |
Why?
|
Adipose Tissue | 10 | 2022 | 3280 | 0.490 |
Why?
|
Bone Regeneration | 4 | 2019 | 427 | 0.480 |
Why?
|
Caregivers | 4 | 2020 | 2095 | 0.480 |
Why?
|
Temporal Muscle | 1 | 2013 | 37 | 0.460 |
Why?
|
Diagnostic Self Evaluation | 1 | 2015 | 230 | 0.440 |
Why?
|
Breast Neoplasms | 5 | 2023 | 20824 | 0.440 |
Why?
|
Antibiotic Prophylaxis | 1 | 2018 | 639 | 0.430 |
Why?
|
Patient Care Planning | 1 | 2018 | 921 | 0.420 |
Why?
|
Wounds and Injuries | 7 | 2017 | 2400 | 0.410 |
Why?
|
Mandibular Fractures | 2 | 2022 | 73 | 0.400 |
Why?
|
Postoperative Care | 1 | 2018 | 1487 | 0.390 |
Why?
|
Surgical Wound Infection | 2 | 2018 | 1540 | 0.390 |
Why?
|
Adaptive Immunity | 1 | 2016 | 714 | 0.390 |
Why?
|
Collagen | 3 | 2019 | 2688 | 0.390 |
Why?
|
Emergency Medical Services | 1 | 2023 | 1917 | 0.390 |
Why?
|
Health Status Indicators | 1 | 2016 | 970 | 0.380 |
Why?
|
Tenotomy | 4 | 2018 | 49 | 0.350 |
Why?
|
Osteoblasts | 4 | 2019 | 1166 | 0.330 |
Why?
|
Activin Receptors, Type I | 4 | 2017 | 142 | 0.330 |
Why?
|
Telemedicine | 2 | 2023 | 2872 | 0.330 |
Why?
|
Preoperative Care | 1 | 2018 | 2251 | 0.330 |
Why?
|
Mastectomy | 3 | 2023 | 1793 | 0.320 |
Why?
|
Quality-Adjusted Life Years | 4 | 2023 | 1683 | 0.320 |
Why?
|
Fracture Healing | 2 | 2021 | 427 | 0.310 |
Why?
|
Health Services Accessibility | 3 | 2022 | 5135 | 0.300 |
Why?
|
Internship and Residency | 4 | 2023 | 5791 | 0.290 |
Why?
|
Humans | 61 | 2024 | 744366 | 0.280 |
Why?
|
Neurosurgical Procedures | 1 | 2018 | 2002 | 0.280 |
Why?
|
Decision Making | 1 | 2020 | 3888 | 0.280 |
Why?
|
Mammaplasty | 1 | 2016 | 1204 | 0.270 |
Why?
|
Bone Morphogenetic Proteins | 3 | 2016 | 838 | 0.270 |
Why?
|
Employment | 2 | 2023 | 1132 | 0.270 |
Why?
|
Hand Injuries | 2 | 2020 | 242 | 0.260 |
Why?
|
Tomography, X-Ray Computed | 7 | 2021 | 20130 | 0.260 |
Why?
|
Craniofacial Abnormalities | 3 | 2020 | 315 | 0.260 |
Why?
|
Ultrasonography | 1 | 2018 | 5984 | 0.250 |
Why?
|
Body Image | 3 | 2019 | 610 | 0.240 |
Why?
|
Cell Differentiation | 8 | 2019 | 11486 | 0.240 |
Why?
|
Female | 35 | 2024 | 380193 | 0.240 |
Why?
|
Mandible | 2 | 2021 | 740 | 0.240 |
Why?
|
Wound Healing | 5 | 2019 | 2785 | 0.230 |
Why?
|
Disease Models, Animal | 10 | 2018 | 18034 | 0.230 |
Why?
|
Health Status | 1 | 2016 | 4034 | 0.220 |
Why?
|
Achilles Tendon | 2 | 2015 | 157 | 0.220 |
Why?
|
Washington | 1 | 2023 | 313 | 0.220 |
Why?
|
Delivery of Health Care | 2 | 2023 | 5321 | 0.210 |
Why?
|
Male | 33 | 2024 | 350115 | 0.210 |
Why?
|
Reoperation | 4 | 2019 | 4201 | 0.200 |
Why?
|
X-Ray Microtomography | 3 | 2022 | 428 | 0.190 |
Why?
|
Cell Extracts | 1 | 2021 | 138 | 0.190 |
Why?
|
Anti-Bacterial Agents | 1 | 2018 | 7182 | 0.180 |
Why?
|
Child | 14 | 2020 | 77709 | 0.170 |
Why?
|
Tissue Banks | 1 | 2020 | 184 | 0.170 |
Why?
|
Medicaid | 2 | 2023 | 2737 | 0.170 |
Why?
|
Gold | 1 | 2023 | 484 | 0.170 |
Why?
|
Attitude to Health | 2 | 2019 | 2052 | 0.170 |
Why?
|
Integrases | 3 | 2019 | 533 | 0.170 |
Why?
|
Deferoxamine | 1 | 2019 | 151 | 0.170 |
Why?
|
Rats, Inbred Lew | 4 | 2022 | 1162 | 0.160 |
Why?
|
Infrared Rays | 1 | 2019 | 249 | 0.160 |
Why?
|
Prejudice | 1 | 2022 | 570 | 0.160 |
Why?
|
Wrist | 1 | 2020 | 224 | 0.160 |
Why?
|
Forehead | 1 | 2018 | 69 | 0.160 |
Why?
|
Personal Satisfaction | 2 | 2019 | 643 | 0.150 |
Why?
|
Animals | 24 | 2022 | 168768 | 0.150 |
Why?
|
Gender Identity | 1 | 2023 | 687 | 0.150 |
Why?
|
Databases, Factual | 3 | 2023 | 7730 | 0.150 |
Why?
|
MAP Kinase Kinase Kinases | 1 | 2019 | 261 | 0.150 |
Why?
|
Bone Morphogenetic Protein Receptors | 1 | 2017 | 47 | 0.150 |
Why?
|
Wrist Injuries | 1 | 2020 | 208 | 0.150 |
Why?
|
Biological Availability | 1 | 2018 | 397 | 0.150 |
Why?
|
Facial Muscles | 1 | 2018 | 157 | 0.150 |
Why?
|
Faculty | 1 | 2020 | 387 | 0.150 |
Why?
|
Intraoperative Care | 1 | 2021 | 767 | 0.150 |
Why?
|
Chondrogenesis | 2 | 2015 | 247 | 0.150 |
Why?
|
Adolescent | 11 | 2022 | 85779 | 0.150 |
Why?
|
Speech Intelligibility | 1 | 2017 | 81 | 0.150 |
Why?
|
Bibliometrics | 1 | 2020 | 339 | 0.140 |
Why?
|
Intraoperative Complications | 1 | 2024 | 1198 | 0.140 |
Why?
|
Tendons | 2 | 2018 | 548 | 0.140 |
Why?
|
Postoperative Complications | 2 | 2017 | 15297 | 0.140 |
Why?
|
Patient Satisfaction | 3 | 2019 | 3395 | 0.140 |
Why?
|
Postoperative Period | 2 | 2021 | 1842 | 0.140 |
Why?
|
Injections, Subcutaneous | 1 | 2018 | 667 | 0.140 |
Why?
|
Burns, Electric | 1 | 2016 | 42 | 0.140 |
Why?
|
Gene Targeting | 2 | 2017 | 880 | 0.140 |
Why?
|
Europe | 1 | 2023 | 3338 | 0.140 |
Why?
|
Adipocytes | 2 | 2020 | 1185 | 0.140 |
Why?
|
Mice | 16 | 2022 | 81201 | 0.140 |
Why?
|
Child, Preschool | 8 | 2021 | 41005 | 0.140 |
Why?
|
Arnold-Chiari Malformation | 1 | 2018 | 154 | 0.140 |
Why?
|
Triage | 1 | 2023 | 977 | 0.130 |
Why?
|
Jejunum | 1 | 2018 | 480 | 0.130 |
Why?
|
Myositis Ossificans | 1 | 2016 | 79 | 0.130 |
Why?
|
Stem Cell Transplantation | 2 | 2015 | 1620 | 0.130 |
Why?
|
Incidence | 3 | 2023 | 20952 | 0.130 |
Why?
|
Muscular Atrophy | 1 | 2018 | 347 | 0.130 |
Why?
|
Facial Neoplasms | 1 | 2016 | 121 | 0.130 |
Why?
|
Hair Follicle | 1 | 2017 | 208 | 0.130 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 2 | 2015 | 627 | 0.130 |
Why?
|
Mesenchymal Stem Cell Transplantation | 2 | 2019 | 496 | 0.120 |
Why?
|
Protein-Lysine 6-Oxidase | 1 | 2014 | 59 | 0.120 |
Why?
|
Osteocytes | 1 | 2016 | 197 | 0.120 |
Why?
|
Tissue Transplantation | 1 | 2015 | 130 | 0.120 |
Why?
|
Cost of Illness | 1 | 2024 | 1860 | 0.120 |
Why?
|
Appointments and Schedules | 1 | 2018 | 417 | 0.120 |
Why?
|
Rectus Abdominis | 1 | 2014 | 97 | 0.120 |
Why?
|
India | 1 | 2020 | 2197 | 0.120 |
Why?
|
Young Adult | 7 | 2019 | 56429 | 0.120 |
Why?
|
Osteogenesis, Distraction | 1 | 2016 | 219 | 0.120 |
Why?
|
Attitude of Health Personnel | 2 | 2019 | 3841 | 0.110 |
Why?
|
Career Choice | 2 | 2020 | 744 | 0.110 |
Why?
|
Michigan | 3 | 2020 | 350 | 0.110 |
Why?
|
Parent-Child Relations | 1 | 2017 | 747 | 0.110 |
Why?
|
Mentors | 1 | 2018 | 631 | 0.110 |
Why?
|
Abdominal Wall | 1 | 2014 | 157 | 0.110 |
Why?
|
Early Diagnosis | 1 | 2018 | 1184 | 0.110 |
Why?
|
Decompression, Surgical | 1 | 2018 | 594 | 0.110 |
Why?
|
Arthroplasty | 1 | 2015 | 305 | 0.110 |
Why?
|
Mothers | 1 | 2023 | 2165 | 0.110 |
Why?
|
Social Adjustment | 1 | 2015 | 631 | 0.110 |
Why?
|
Rats | 5 | 2022 | 24252 | 0.110 |
Why?
|
Internationality | 1 | 2018 | 1002 | 0.110 |
Why?
|
Speech Perception | 1 | 2017 | 490 | 0.110 |
Why?
|
Mice, Inbred Strains | 1 | 2015 | 1828 | 0.110 |
Why?
|
Parents | 3 | 2021 | 3405 | 0.110 |
Why?
|
Muscular Diseases | 1 | 2017 | 555 | 0.110 |
Why?
|
Rural Population | 1 | 2022 | 2207 | 0.100 |
Why?
|
Neurofibromatoses | 1 | 2016 | 299 | 0.100 |
Why?
|
Logistic Models | 2 | 2018 | 13409 | 0.100 |
Why?
|
Insurance Coverage | 1 | 2023 | 1900 | 0.100 |
Why?
|
Health Services Research | 1 | 2019 | 1836 | 0.100 |
Why?
|
Hernia, Ventral | 1 | 2014 | 176 | 0.100 |
Why?
|
Mice, Inbred C57BL | 7 | 2019 | 21833 | 0.100 |
Why?
|
General Surgery | 1 | 2023 | 1636 | 0.100 |
Why?
|
Adult | 12 | 2024 | 214052 | 0.100 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2016 | 713 | 0.100 |
Why?
|
Regeneration | 2 | 2017 | 1485 | 0.100 |
Why?
|
United States | 7 | 2023 | 69872 | 0.100 |
Why?
|
Cross-Sectional Studies | 4 | 2022 | 25039 | 0.100 |
Why?
|
Antifibrinolytic Agents | 1 | 2014 | 254 | 0.100 |
Why?
|
SOX9 Transcription Factor | 3 | 2016 | 146 | 0.100 |
Why?
|
Iron | 1 | 2019 | 1774 | 0.090 |
Why?
|
Random Allocation | 1 | 2015 | 2428 | 0.090 |
Why?
|
Skin | 3 | 2019 | 4372 | 0.090 |
Why?
|
Analysis of Variance | 2 | 2019 | 6366 | 0.090 |
Why?
|
Peer Group | 1 | 2015 | 635 | 0.090 |
Why?
|
Administration, Oral | 1 | 2018 | 3914 | 0.090 |
Why?
|
Signal Transduction | 7 | 2019 | 23404 | 0.090 |
Why?
|
Extracellular Matrix Proteins | 1 | 2014 | 850 | 0.090 |
Why?
|
Health Expenditures | 1 | 2023 | 2349 | 0.090 |
Why?
|
Artificial Intelligence | 1 | 2023 | 2213 | 0.090 |
Why?
|
Retrospective Studies | 11 | 2023 | 77460 | 0.090 |
Why?
|
Treatment Outcome | 6 | 2021 | 63107 | 0.090 |
Why?
|
Biopsy, Needle | 1 | 2015 | 1641 | 0.090 |
Why?
|
Stem Cells | 3 | 2022 | 3567 | 0.090 |
Why?
|
Health Personnel | 1 | 2023 | 3219 | 0.090 |
Why?
|
Blood Loss, Surgical | 1 | 2014 | 662 | 0.090 |
Why?
|
Imaging, Three-Dimensional | 3 | 2019 | 4042 | 0.090 |
Why?
|
Cell Survival | 1 | 2019 | 5882 | 0.080 |
Why?
|
Prevalence | 2 | 2023 | 15221 | 0.080 |
Why?
|
Prostheses and Implants | 1 | 2016 | 1387 | 0.080 |
Why?
|
Prospective Studies | 3 | 2024 | 53290 | 0.080 |
Why?
|
Bone Density Conservation Agents | 1 | 2015 | 772 | 0.080 |
Why?
|
Surgery, Computer-Assisted | 1 | 2016 | 1018 | 0.080 |
Why?
|
Transplantation, Autologous | 1 | 2013 | 2124 | 0.080 |
Why?
|
Patient Compliance | 1 | 2018 | 2684 | 0.070 |
Why?
|
Leptin | 1 | 2015 | 1600 | 0.070 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2016 | 2110 | 0.070 |
Why?
|
Blotting, Western | 1 | 2015 | 5181 | 0.070 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2015 | 2016 | 0.070 |
Why?
|
Blood Transfusion | 1 | 2014 | 1301 | 0.070 |
Why?
|
Sex Factors | 3 | 2015 | 10400 | 0.070 |
Why?
|
Fractures, Bone | 1 | 2019 | 1947 | 0.070 |
Why?
|
Follow-Up Studies | 3 | 2018 | 39052 | 0.070 |
Why?
|
Intensive Care Units | 1 | 2020 | 3680 | 0.070 |
Why?
|
Patient Care Team | 1 | 2018 | 2531 | 0.070 |
Why?
|
Feasibility Studies | 1 | 2016 | 5077 | 0.070 |
Why?
|
Cell Proliferation | 2 | 2019 | 10483 | 0.070 |
Why?
|
Migraine Disorders | 1 | 2018 | 1620 | 0.070 |
Why?
|
Polymerase Chain Reaction | 1 | 2015 | 6171 | 0.070 |
Why?
|
Risk Factors | 4 | 2023 | 72296 | 0.070 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2015 | 2282 | 0.060 |
Why?
|
Risk Assessment | 2 | 2018 | 23336 | 0.060 |
Why?
|
Reproducibility of Results | 3 | 2022 | 19905 | 0.060 |
Why?
|
Mice, Transgenic | 4 | 2019 | 9735 | 0.060 |
Why?
|
Muscle, Skeletal | 2 | 2017 | 4925 | 0.060 |
Why?
|
Cohort Studies | 3 | 2024 | 40559 | 0.060 |
Why?
|
Sepsis | 1 | 2018 | 2593 | 0.060 |
Why?
|
Receptor, Platelet-Derived Growth Factor alpha | 2 | 2016 | 378 | 0.060 |
Why?
|
Head and Neck Neoplasms | 1 | 2018 | 2736 | 0.060 |
Why?
|
Inflammation | 3 | 2018 | 10637 | 0.060 |
Why?
|
Orbit | 2 | 2018 | 426 | 0.060 |
Why?
|
Endothelial Cells | 1 | 2016 | 3486 | 0.060 |
Why?
|
Cell Line | 1 | 2018 | 16000 | 0.060 |
Why?
|
Organ Size | 2 | 2018 | 2251 | 0.060 |
Why?
|
Age Factors | 3 | 2016 | 18373 | 0.060 |
Why?
|
Apoptosis | 1 | 2019 | 9724 | 0.050 |
Why?
|
Algorithms | 1 | 2023 | 13882 | 0.050 |
Why?
|
Graft Survival | 1 | 2013 | 3737 | 0.050 |
Why?
|
Infant | 3 | 2021 | 35134 | 0.050 |
Why?
|
Ghana | 1 | 2023 | 284 | 0.050 |
Why?
|
Students, Medical | 1 | 2015 | 1862 | 0.050 |
Why?
|
Middle Aged | 7 | 2018 | 213390 | 0.050 |
Why?
|
Bone Marrow Cells | 2 | 2022 | 2513 | 0.050 |
Why?
|
Immunohistochemistry | 1 | 2015 | 11366 | 0.050 |
Why?
|
Cells, Cultured | 4 | 2020 | 19233 | 0.050 |
Why?
|
Job Application | 1 | 2020 | 39 | 0.050 |
Why?
|
Aged | 4 | 2018 | 163288 | 0.050 |
Why?
|
Fibrosis | 2 | 2017 | 2029 | 0.040 |
Why?
|
Preoperative Period | 1 | 2021 | 550 | 0.040 |
Why?
|
Sirolimus | 2 | 2016 | 1565 | 0.040 |
Why?
|
DNA Nucleotidyltransferases | 1 | 2019 | 193 | 0.040 |
Why?
|
Founder Effect | 1 | 2019 | 189 | 0.040 |
Why?
|
Geography | 1 | 2020 | 669 | 0.040 |
Why?
|
Methylmethacrylate | 1 | 2018 | 44 | 0.040 |
Why?
|
Sus scrofa | 1 | 2019 | 437 | 0.040 |
Why?
|
Trauma Severity Indices | 1 | 2019 | 481 | 0.040 |
Why?
|
Frontal Bone | 1 | 2018 | 105 | 0.040 |
Why?
|
Dose-Response Relationship, Radiation | 1 | 2019 | 876 | 0.040 |
Why?
|
Speech Disorders | 1 | 2018 | 189 | 0.040 |
Why?
|
Esthetics | 1 | 2018 | 306 | 0.040 |
Why?
|
Bone Morphogenetic Protein Receptors, Type I | 1 | 2017 | 96 | 0.040 |
Why?
|
Stromal Cells | 1 | 2022 | 1355 | 0.040 |
Why?
|
Aggrecans | 1 | 2016 | 90 | 0.040 |
Why?
|
Nerve Compression Syndromes | 1 | 2018 | 160 | 0.040 |
Why?
|
Mice, Knockout | 3 | 2017 | 14561 | 0.040 |
Why?
|
Mustard Compounds | 1 | 2015 | 4 | 0.040 |
Why?
|
Hypertrophy | 1 | 2018 | 569 | 0.030 |
Why?
|
Phenylpropionates | 1 | 2015 | 30 | 0.030 |
Why?
|
Receptor, TIE-2 | 1 | 2016 | 178 | 0.030 |
Why?
|
Body Mass Index | 1 | 2013 | 12721 | 0.030 |
Why?
|
Vascular Endothelial Growth Factor B | 1 | 2014 | 25 | 0.030 |
Why?
|
United States Food and Drug Administration | 1 | 2023 | 1584 | 0.030 |
Why?
|
Intraoperative Period | 1 | 2016 | 520 | 0.030 |
Why?
|
Transplantation, Isogeneic | 1 | 2015 | 257 | 0.030 |
Why?
|
Mice, Obese | 1 | 2015 | 425 | 0.030 |
Why?
|
Hindlimb | 1 | 2016 | 504 | 0.030 |
Why?
|
Peripheral Nerves | 1 | 2018 | 466 | 0.030 |
Why?
|
Gene Knockout Techniques | 1 | 2017 | 808 | 0.030 |
Why?
|
Sickness Impact Profile | 1 | 2015 | 302 | 0.030 |
Why?
|
Fascia | 1 | 2014 | 135 | 0.030 |
Why?
|
Chondrocytes | 1 | 2019 | 804 | 0.030 |
Why?
|
Blood Cells | 1 | 2016 | 309 | 0.030 |
Why?
|
Luminescent Measurements | 1 | 2015 | 405 | 0.030 |
Why?
|
Luminescent Proteins | 1 | 2016 | 853 | 0.030 |
Why?
|
Morphogenesis | 1 | 2017 | 751 | 0.030 |
Why?
|
Psychology | 1 | 2015 | 356 | 0.030 |
Why?
|
Anthropometry | 1 | 2018 | 1350 | 0.030 |
Why?
|
Self-Assessment | 1 | 2015 | 390 | 0.030 |
Why?
|
Information Systems | 1 | 2015 | 410 | 0.030 |
Why?
|
Aged, 80 and over | 1 | 2018 | 57776 | 0.030 |
Why?
|
Bone Transplantation | 1 | 2018 | 907 | 0.030 |
Why?
|
New York | 1 | 2015 | 886 | 0.030 |
Why?
|
Models, Animal | 1 | 2019 | 2173 | 0.030 |
Why?
|
Hematocrit | 1 | 2014 | 636 | 0.030 |
Why?
|
Tissue Scaffolds | 1 | 2019 | 956 | 0.030 |
Why?
|
Fellowships and Scholarships | 1 | 2020 | 1078 | 0.030 |
Why?
|
Bone Development | 1 | 2015 | 483 | 0.030 |
Why?
|
Protein Kinase Inhibitors | 2 | 2019 | 5534 | 0.030 |
Why?
|
Cadherins | 1 | 2016 | 907 | 0.030 |
Why?
|
Cartilage | 1 | 2015 | 818 | 0.030 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2015 | 11726 | 0.020 |
Why?
|
California | 1 | 2015 | 1402 | 0.020 |
Why?
|
Subcutaneous Fat | 1 | 2014 | 391 | 0.020 |
Why?
|
Bone Marrow Transplantation | 1 | 2019 | 2765 | 0.020 |
Why?
|
Orthopedic Procedures | 1 | 2021 | 1289 | 0.020 |
Why?
|
Statistics as Topic | 1 | 2017 | 2373 | 0.020 |
Why?
|
Radiation Dosage | 1 | 2019 | 1928 | 0.020 |
Why?
|
Critical Care | 1 | 2023 | 2647 | 0.020 |
Why?
|
Ligands | 1 | 2017 | 3282 | 0.020 |
Why?
|
Models, Biological | 2 | 2017 | 9584 | 0.020 |
Why?
|
Academic Medical Centers | 1 | 2020 | 2760 | 0.020 |
Why?
|
Forecasting | 1 | 2019 | 2951 | 0.020 |
Why?
|
Face | 1 | 2015 | 994 | 0.020 |
Why?
|
Prosthesis Design | 1 | 2016 | 2110 | 0.020 |
Why?
|
Disability Evaluation | 1 | 2016 | 1828 | 0.020 |
Why?
|
Mental Health | 1 | 2023 | 3010 | 0.020 |
Why?
|
Erythrocyte Transfusion | 1 | 2014 | 565 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 2021 | 8642 | 0.020 |
Why?
|
Adaptation, Physiological | 1 | 2015 | 1312 | 0.020 |
Why?
|
Acute Disease | 1 | 2018 | 7147 | 0.020 |
Why?
|
Self Report | 1 | 2018 | 3553 | 0.020 |
Why?
|
Anti-Inflammatory Agents | 1 | 2017 | 1790 | 0.020 |
Why?
|
Clinical Competence | 1 | 2023 | 4687 | 0.020 |
Why?
|
Neovascularization, Physiologic | 1 | 2014 | 1351 | 0.020 |
Why?
|
Spine | 1 | 2014 | 1144 | 0.020 |
Why?
|
Gene Regulatory Networks | 1 | 2015 | 1707 | 0.020 |
Why?
|
Up-Regulation | 1 | 2015 | 4222 | 0.020 |
Why?
|
Fibroblasts | 1 | 2016 | 4162 | 0.020 |
Why?
|
NF-kappa B | 1 | 2014 | 2499 | 0.020 |
Why?
|
Recurrence | 1 | 2018 | 8340 | 0.020 |
Why?
|
Psychometrics | 1 | 2015 | 3003 | 0.020 |
Why?
|
Critical Illness | 1 | 2018 | 2670 | 0.020 |
Why?
|
Patient Acceptance of Health Care | 1 | 2018 | 3020 | 0.020 |
Why?
|
Neutrophils | 1 | 2017 | 3721 | 0.020 |
Why?
|
Multivariate Analysis | 1 | 2018 | 12244 | 0.020 |
Why?
|
Adaptation, Psychological | 1 | 2015 | 2575 | 0.020 |
Why?
|
Sensitivity and Specificity | 1 | 2019 | 14723 | 0.010 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2014 | 3511 | 0.010 |
Why?
|
Gene Expression | 1 | 2016 | 7798 | 0.010 |
Why?
|
Healthcare Disparities | 1 | 2018 | 3154 | 0.010 |
Why?
|
Quality Improvement | 1 | 2018 | 3749 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2019 | 16690 | 0.010 |
Why?
|
Macrophages | 1 | 2017 | 5660 | 0.010 |
Why?
|
Stress, Psychological | 1 | 2017 | 4245 | 0.010 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2018 | 8949 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2019 | 12073 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2015 | 13035 | 0.010 |
Why?
|
Thrombosis | 1 | 2014 | 2968 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2015 | 15535 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2017 | 17446 | 0.010 |
Why?
|
Depression | 1 | 2015 | 7759 | 0.010 |
Why?
|